Literature DB >> 23999071

Transcriptome profiling of the newborn mouse lung after hypoxia and reoxygenation: hyperoxic reoxygenation affects mTOR signaling pathway, DNA repair, and JNK-pathway regulation.

Embjørg J Wollen1, Yngve Sejersted, Marianne S Wright, Miroslaw Bik-Multanowski, Anna Madetko-Talowska, Clara-Cecilie Günther, Ståle Nygård, Przemko Kwinta, Jacek J Pietrzyk, Ola D Saugstad.   

Abstract

BACKGROUND: The use of oxygen in acute treatment of asphyxiated term newborns is associated with increased mortality. It is unclear how hyperoxic reoxygenation after hypoxia affects transcriptional changes in the newborn lung.
METHODS: On postnatal day 7, C57BL/6 mice (n = 62) were randomized to 120-min hypoxia (fraction of inspired oxygen (FiO2) 0.08) or normoxia. The hypoxia group was further randomized to reoxygenation for 30 min with FiO2 0.21, 0.40, 0.60, or 1.00, and the normoxia group to FiO2 0.21 or 1.00. Transcriptome profiling was performed on homogenized lung tissue using the Affymetrix 750k expression array, and validation was carried out by real-time polymerase chain reaction and enzyme-linked immunosorbent assay.
RESULTS: The hypoxia-reoxygenation model induced hypoxia-inducible factor 1 (HIF-1) targets like Vegfc, Adm, and Aqp1. In total, ~70% of the significantly differentially expressed genes were detected in the two high hyperoxic groups (FiO2 0.60 and 1.00). Reoxygenation with 100% oxygen after hypoxia uniquely upregulated Gadd45g, Dusp1, Peg3, and Tgm2. Pathway analysis identified mammalian target of rapamycin (mTOR) signaling pathway, DNA repair, c-jun N-terminal kinase (JNK)-pathway regulation, and cell cycle after hyperoxic reoxygenation was applied.
CONCLUSION: Acute hypoxia induces HIF-1 targets independent of the reoxygenation regime applied. Hyperoxic reoxygenation affects pathways regulating cell growth and survival. DNA-damage-responsive genes are restricted to reoxygenation with 100% oxygen.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23999071     DOI: 10.1038/pr.2013.140

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  6 in total

1.  The genome-wide transcriptional response to neonatal hyperoxia identifies Ahr as a key regulator.

Authors:  Soumyaroop Bhattacharya; Zhongyang Zhou; Min Yee; Chin-Yi Chu; Ashley M Lopez; Valerie A Lunger; Siva Kumar Solleti; Emily Resseguie; Bradley Buczynski; Thomas J Mariani; Michael A O'Reilly
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-08-22       Impact factor: 5.464

Review 2.  The fetal circulation, pathophysiology of hypoxemic respiratory failure and pulmonary hypertension in neonates, and the role of oxygen therapy.

Authors:  S Lakshminrusimha; O D Saugstad
Journal:  J Perinatol       Date:  2016-06       Impact factor: 2.521

3.  Transcriptomic analysis identifies a role of PI3K-Akt signalling in the responses of skeletal muscle to acute hypoxia in vivo.

Authors:  Zhuohui Gan; Frank L Powell; Alexander C Zambon; Kyle S Buchholz; Zhenxing Fu; Karen Ocorr; Rolf Bodmer; Esteban A Moya; Jennifer C Stowe; Gabriel G Haddad; Andrew D McCulloch
Journal:  J Physiol       Date:  2017-07-27       Impact factor: 5.182

4.  Short-term perinatal oxygen exposure may impair lung development in adult mice.

Authors:  Vasantha H S Kumar; Huamei Wang; Lori Nielsen
Journal:  Biol Res       Date:  2020-11-10       Impact factor: 5.612

Review 5.  Oxygen Toxicity to the Immature Lung-Part I: Pathomechanistic Understanding and Preclinical Perspectives.

Authors:  Yesi Choi; Lisa Rekers; Ying Dong; Lena Holzfurtner; Maurizio J Goetz; Tayyab Shahzad; Klaus-Peter Zimmer; Judith Behnke; Jonas Behnke; Saverio Bellusci; Harald Ehrhardt
Journal:  Int J Mol Sci       Date:  2021-10-12       Impact factor: 5.923

6.  Effect of sex chromosomes versus hormones in neonatal lung injury.

Authors:  Sandra L Grimm; Xiaoyu Dong; Yuhao Zhang; Alexandre F Carisey; Arthur P Arnold; Bhagavatula Moorthy; Cristian Coarfa; Krithika Lingappan
Journal:  JCI Insight       Date:  2021-07-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.